National Drug Early Warning Network
National Drug Early Warning System Coordinating Center (NDEWS)
This project keeps a national center running that quickly finds and shares alerts about emerging drug trends and new psychoactive substances to help communities and public-health officials.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11261773 on NIH RePORTER |
What this research studies
If you or someone in your community is affected by drug use, this center gathers reports from hospitals, laboratories, harm-reduction groups, and frontline experts to spot new and dangerous drug trends. The team adds new public-health surveillance methods and collects primary data to detect shifts in drug use and new psychoactive substances faster. They hold weekly briefings and expert meetings and send timely alerts to county and state health departments. University partners work together to analyze findings and share actionable information with local responders.
Who could benefit from this research
Good fit: Ideal participants include people who use substances, clinicians, public-health workers, poison center staff, and laboratories willing to report drug-related experiences, samples, or local trend information.
Not a fit: Individuals seeking direct medical treatment or personal therapy should not expect clinical care from this surveillance program, since it focuses on monitoring and alerts rather than individual treatment.
Why it matters
Potential benefit: If successful, this work could lead to earlier warnings about dangerous new drugs and faster public-health responses to reduce harm in communities.
How similar studies have performed: Previous NDEWS activities and other drug-surveillance systems have successfully detected emerging threats, and this renewal builds on those proven methods while adding new tools.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Cottler, Linda B. — University of Florida
- Study coordinator: Cottler, Linda B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.